Combined modality treatment in the management of high-risk prostate cancer

The efficacy of a multimodality protocol using neoadjuvant and concomitant hormonal therapy, brachytherapy, and three-dimensional conformal external beam radiotherapy (RT) in high-risk prostate cancer was evaluated using biochemical outcomes and posttreatment biopsy results. Between February 1994 an...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	International journal of radiation oncology, biology, physics Ročník 59; číslo 5; s. 1352
Hlavní autori:	Stock, Richard G, Cahlon, Oren, Cesaretti, Jamie A, Kollmeier, Marisa A, Stone, Nelson N
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.08.2004
Predmet:	Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Brachytherapy Combined Modality Therapy Finasteride - therapeutic use Flutamide - therapeutic use Gonadotropin-Releasing Hormone - agonists Humans Male Palladium - therapeutic use Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - drug therapy Prostatic Neoplasms - radiotherapy Radioisotopes - therapeutic use Radiotherapy, Conformal Testosterone - blood
ISSN:	0360-3016
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!